Finance

Lists
AFT:NZE
AFT Pharmaceuticals Ltd
4,64 NZ$
+1,98%
(+0,090) 1D
9 қаз., 16:59:42 GMT+13  ·   NZD
All symbols
SymbolPriceChange% Change
Generating top insights for AFT...
Open
4,64 NZ$
High
4,64 NZ$
Low
4,59 NZ$
Mkt. cap
486,62 млн
Avg. vol.
23,65 мың
Volume
63,33 мың
Dividend
0,54%
Quarterly dividend
0,01 NZ$
Ex-dividend date
2026 ж. 18 мау.
P/E ratio
33,03
52-wk high
4,85 NZ$
52-wk low
2,80 NZ$
EPS
0,14 NZ$
Shares outstanding
104,87 млн
No. of employees
126
Open
4,64 NZ$
High
4,64 NZ$
Low
4,59 NZ$
Mkt. cap
486,62 млн
Avg. vol.
23,65 мың
Volume
63,33 мың
Dividend
0,54%
Quarterly dividend
0,01 NZ$
Ex-dividend date
2026 ж. 18 мау.
P/E ratio
33,03
52-wk high
4,85 NZ$
52-wk low
2,80 NZ$
EPS
0,14 NZ$
Shares outstanding
104,87 млн
No. of employees
126
News stories
From web sources and news partners
About AFT Pharmaceuticals Ltd
CEOHartley Atkinson
Employees126
Founded1997
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in NZD
Loading Previous Earnings...
Revenue
Net income
All values in NZD
2025 ж. мау.
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
Revenue
57,47 млн
57,47 млн
69,88 млн
69,88 млн
Cost of goods sold
32,63 млн
32,63 млн
39,45 млн
39,45 млн
Cost of revenue
32,63 млн
32,63 млн
39,45 млн
39,45 млн
Research and development expenses
3,06 млн
3,06 млн
1,86 млн
1,86 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,10 млн
19,10 млн
18,83 млн
18,83 млн
Operating expense
22,48 млн
22,48 млн
20,58 млн
20,58 млн
Total operating expenses
55,10 млн
55,10 млн
60,03 млн
60,03 млн
Operating income
2,37 млн
2,37 млн
9,85 млн
9,85 млн
Other non operating income
462,50 м.
462,50 м.
-886,50 м.
-886,50 м.
EBT including unusual items
2,22 млн
2,22 млн
8,72 млн
8,72 млн
EBT excluding unusual items
2,22 млн
2,22 млн
8,72 млн
8,72 млн
Income tax expense
856,50 м.
856,50 м.
3,04 млн
3,04 млн
Effective tax rate
38,61%
38,61%
34,88%
34,88%
Other operating expenses
318,00 м.
318,00 м.
-113,00 м.
-113,00 м.
Net income
1,65 млн
1,65 млн
5,72 млн
5,72 млн
Net profit margin
2,87%
2,87%
8,18%
8,18%
Earnings per share
-
-
-
-
Interest and investment income
2,50 мың
2,50 мың
500,00
500,00
Interest expense
-615,00 м.
-615,00 м.
-628,00 м.
-628,00 м.
Net interest expenses
-612,50 м.
-612,50 м.
-627,50 м.
-627,50 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
3,07 млн
3,07 млн
11,00 млн
11,00 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары